Sat 28 Nov 2009 | 4:12 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Seattle Genetics

Seattle Genetics (SGEN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View SGEN on other exchanges
As of  27 Nov 2009
9.39USD
Price Change
-0.24
Percent Change
-2.49%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Schumacher, Kirk -- 2009 Vice President - Legal Affairs and Compliance, General Counsel
Baker, Felix 40 2005 Lead Director
Siegall, Clay 48 2004 Interim Chairman of the Board, President, Chief Executive Officer
Rosenberg, Morris 49 2009 Executive Vice President - Development
Seeley, Bruce -- 2009 Executive Vice President - Commercial
Lippman, Marc 64 2000 Director
Akkaraju, Srinivas 41 2003 Director
Berger, Franklin 59 2004 Director
Gryska, David 53 2005 Director
Hoth, Daniel 63 2006 Director
McLaughlin, John 57 2007 Director
Welch, Daniel 51 2007 Director
Reynolds, Thomas 50 2007 Chief Medical Officer
Simpson, Todd 48 2005 Chief Financial Officer
Dobmeier, Eric 40 2007 Chief Business Officer and Corporate Secretary